ghk-cu peptide subcutaneous Copper Thermodynamically stable ionic liquid microemulsions

These findings came from one research programme and require consideration of mouse strain, housing conditions, dose pattern and statistical methods

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

From accelerating wound healing and stimulating hair regrowth to its foundational role in reducing inflammation and resetting cellular gene expression, GHK-Cu represents a sophisticated approach to regenerative medicine

In addition, the expression and activity of NOS correlate with the growth and aggressiveness of human tumors [116,119,120]